Discovery

Explore Topics Papers

Docs Terms Privacy

Search Kritoma

Recent searches

Searches you run from this bar will appear here.

CAR-T and engineered T cell therapies

Clinical MedicineUpdated Oct 5, 2026Version v1

Knowledge Timeline Gaps (1)Evidence (307)Community (0)

Evidence

Public papers linked to this topic and used as evidence for gaps, timelines, and knowledge views.

307 papers

SearchSort evidence

All307 Core249 Supporting83 Background0

Showing 85-96 of total 307 evidence records.

Open a paper to inspect abstract, source links, and topic context.

2026PubMedDirectly related

Advances in CAR-T Cell Therapy: From Structural Design Innovations to Clinical Translation Challenges.

Gao H; Fang Y; Zhang P; Qian Q

Jan 1, 2026

Journal of Cancer

2026PubMedDirectly related

Engineered Bacteriophages in Cancer Immunotherapy: Emerging Concepts and Potential Integration with CAR-T Cell Therapy.

Alrahimi J

Jan 1, 2026Folia biologica

2026PubMedDirectly related

Biomaterial Techniques for Enhancing CAR-T Cell Therapy of Solid Tumours.

Chilvers K; Maher J

Jan 1, 2026Cancers

2026PubMedDirectly related

The carbon footprint of Chimeric Antigen Receptor-T cell manufacturing processes.

van der Bijl WE; Gareb B; Klomberg KM; Bremer E; van Meerten T; Oude Munnink TH; Dekkers BGJ

Jan 1, 2026International journal of pharmaceutics: X

2026PubMedDirectly related

Engineering next-generation CAR-T cells for glioblastoma treatment: a review of innovations in receptor design, antigen targeting, and therapeutic persistence.

Królikowska A; Białkowska K

Jan 1, 2026International immunopharmacology

2026PubMedDirectly related

Multi-Omics-Enabled Precision Strategies for Overcoming CAR-T Therapy Limitations in Gastrointestinal Malignancies.

Su K; Tan Z; Li H; You K; Xiao S; Chen H; Li D; Liu X; Du X; Hu J; He K; Xu Y; Chen J; Han Y

Jan 1, 2026BioFactors (Oxford, England)

2026PubMedDirectly related

A generalizable covalent car-t platform for solid tumors enabled by oncolytic adenovirus-delivered artificial antigens.

Guo L; Xie H; Yin D; Zhu G; Zhai P; Pei G; Zhang W; Xiao F; Lyu J; Tang D

Jan 1, 2026Frontiers in immunology

2026PubMedDirectly related

Control of breast cancer patient-derived xenografts by CD70-targeted HIT-CAR T cells.

Lindenbergh PL; Rajasekhar VK; Linkov I; Mansilla-Soto J; Hanina SA; Sadelain M

Jan 1, 2026Frontiers in immunology

2026PubMedSupporting evidence

Comprehensive microRNA profiling coupled with function-based feature selection reveals a biomarker panel for predicting CAR-T cell exhaustion.

Nakamura N; Seo H; Hamada R; Kaneko H; Kagoya Y; Ohta S

Jan 1, 2026Biochemical and biophysical research communications

2026PubMedDirectly related

Perioperative myeloid cell remodeling shapes CAR-T cell efficacy in glioblastoma.

Pedard M; Castillo Cantero L; Ghasemi A; Marinari E; Mollica C; Davanture S; Pernot J; Widmer V; Merkler D; Egervari K; Schaller K; Bijlenga P; Bartoli A; Momjian S; Pittet MJ; Dutoit V; Migliorini D

Jan 1, 2026Nature communications

2026PubMedDirectly related

Cancer-driver-agnostic targeting of amplified surface proteins identifies MPZL1 for selective CAR-T cell therapy.

Jiménez-Vázquez S; Berthel A; Patsis C; Mitstorfer M; Grimm M; Butthof L; Wendler-Link L; Böse L; Wiethoff H; Hofmann I; Breuhahn K; Longerich T; Gaida MM; Schirmacher P; Feucht J; Suarez-Carmona M; Schmidt P; Klupp F; Schneider M; Wallwiener M; Jaeger D; Halama N; Breinig M; Tschaharganeh DF

Jan 1, 2026Nature communications

2026PubMedDirectly related

Mechanism and intervention strategy of thymus atrophy in cancer immunotherapy.

Zhang H; Zhang F; Li T; Xu S; Cui L

Jan 1, 2026American journal of cancer research

Page 8 of 26Showing 85-96 of total 307 results.

1...789...26

CAR-T and engineered T cell therapies — Research Evidence and Topic Memory | Kritoma